跳至主要内容
临床试验/NL-OMON43868
NL-OMON43868已完成不适用

ow-flow extracorporeal CO2 removal in patients with moderate ARDS to enhance lung protective ventilation. Pilot feasibility and safety study - SUPERNOVA

European Society of Intensive Care Medicine (ESICM)0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - moderately severe ARDS according to the Berlin definition(16);PaO2/FiO2: 200-100 mmHg, with PEEP * 5 cmH2O
  • - expected duration of ventilation >24h

排除标准

  • - Age <18 years
  • - Pregnancy
  • - Decompensated heart insufficiency or acute coronary syndrome - Severe COPD
  • - Major respiratory acidosis PaCO2>60 mmHg
  • - Acute brain injury
  • - Severe liver insufficiency (Child-Pugh scores >7) or fulminant hepatic failure
  • - Heparin-induced thrombocytopenia (HIT)
  • - Contraindication for systemic anticoagulation
  • - Patient moribund, decision to limit therapeutic interventions
  • - Catheter access to femoral vein or jugular vein impossible
  • - Pneumothorax
  • - Platelet <50 G/l

研究者

相似试验

ow-flow extracorporeal CO2 removal in patients with... | 临床试验